ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,081Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 1006

$794K Total Retail Price of All Prescriptions

Rank: 80 out of 1006

442 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,352 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 532 425 1 2
WARFARIN SODIUM 483 288 2 8
FUROSEMIDE 447 400 3 6
METOPROLOL TARTRATE 376 276 4 7
SIMVASTATIN 325 278 5 1
LISINOPRIL 291 237 6 3
TRAZODONE HCL 287 247 7 21
AMLODIPINE BESYLATE 273 246 8 4
GABAPENTIN 245 141 9 20
METFORMIN HCL 237 217 10 10
ATORVASTATIN CALCIUM 237 208 10 5
MIRTAZAPINE 232 189 12 26
OMEPRAZOLE 207 175 13 9
POTASSIUM CHLORIDE 201 186 14 30
CITALOPRAM HBR 198 147 15 24
DONEPEZIL HCL 197 180 16 17
PREDNISONE 185 150 17 33
METOPROLOL SUCCINATE 177 162 18 12
PRAVASTATIN SODIUM 173 128 19 15
TAMSULOSIN HCL 168 148 20 23
NAMENDA 161 142 21 34
QUETIAPINE FUMARATE 139 90 22 45
ESCITALOPRAM OXALATE 137 124 23 27
PANTOPRAZOLE SODIUM 126 85 24 32
RISPERIDONE 116 116 25 40
SERTRALINE HCL 115 94 26 19
HYDRALAZINE HCL 114 102 27 100
HYDROCHLOROTHIAZIDE 113 108 28 11
CYMBALTA 111 91 29 41
BACLOFEN 103 42 30 95
ATENOLOL 100 91 31 13
DIVALPROEX SODIUM 95 59 32 53
ZOLPIDEM TARTRATE 94 70 33 14
ADVAIR DISKUS 93 79 34 37
OXYCODONE HCL 89 61 S2 35 54
ALENDRONATE SODIUM 87 56 36 29
SPIRIVA 87 75 36 48
LANTUS 77 47 38 43
LEVETIRACETAM 75 40 39 72
FENTANYL 73 73 S2 40 74
NEXIUM 72 61 41 28
CLOPIDOGREL 71 64 42 46
OXYBUTYNIN CHLORIDE ER 70 32 43 92
DILTIAZEM 24HR CD 69 31 44 88
LOSARTAN POTASSIUM 68 67 45 22
ALLOPURINOL 67 45 46 31
CARVEDILOL 65 57 47 36
SEROQUEL 64 33 48 97
LEVOFLOXACIN 62 55 49 96
DOXAZOSIN MESYLATE 62 47 49 87
IPRATROPIUM-ALBUTEROL 61 31 51 73
CRESTOR 61 48 51 18
ISOSORBIDE MONONITRATE ER 59 59 53 59
PHENYTOIN SODIUM EXTENDED 59 37 53 149
OXYCODONE-ACETAMINOPHEN 58 53 S2 55 57
ABILIFY 58 43 55 102
GLIPIZIDE 56 44 57 69
LACTULOSE 56 49 57 104
DIOVAN 54 54 59 16
CIPROFLOXACIN HCL 54 46 59 75
DIGOXIN 52 52 61 52
PAROXETINE HCL 51 27 62 62
DIVALPROEX SODIUM ER 51 39 62 127
FAMOTIDINE 50 44 64 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.